Does a frozen embryo transfer ameliorate the effect of elevated progesterone seen in fresh transfer cycles?

Fertil Steril. 2016 Jan;105(1):93-9.e1. doi: 10.1016/j.fertnstert.2015.09.015. Epub 2015 Oct 9.

Abstract

Objective: To compare the effect of progesterone (P) on the day of trigger in fresh assisted reproduction technology (ART) transfer cycles versus its effect on subsequent frozen embryo transfer (FET) cycles.

Design: Retrospective cohort study.

Setting: Large private ART practice.

Patient(s): Fresh autologous and FET cycles from 2011-2013.

Intervention(s): None.

Main outcome measure(s): Live birth.

Result(s): A paired analysis of patients who underwent both a fresh transfer and subsequent FET cycle and an unpaired analysis of data from all fresh transfer cycles and all FET cycles were performed. We analyzed 1,216 paired and 4,124 unpaired cycles, and P was negatively associated with birth in fresh but not FET cycles in all analyses. Interaction testing of P and cycle type indicated P had a different association with birth in fresh versus FET cycles. When P was ≥ 2 ng/mL at the time of trigger, live birth was more likely in FET versus fresh cycles in the paired analysis (47% vs. 10%), in the unpaired analysis (51% vs. 14%), and in unpaired, good blastocyst only transfer subgroup (51% vs. 29%). Live birth was similar in FET cycles, with P ≥ 2 ng/mL versus P < 2 ng/mL (51% vs. 49%). Conversely, live birth was lower in fresh cycles, with P ≥ 2 ng/mL versus P <2 ng/mL (15% vs. 45%).

Conclusion(s): Elevated P levels on the day of trigger during the initial fresh cycle were negatively associated with live birth in the fresh transfer cycles but not in subsequent FET cycles. Freezing embryos and performing a subsequent FET cycle ameliorates the effect of elevated P on live-birth rates.

Keywords: Elevated progesterone; fresh transfer versus FET cycles; live birth.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers / blood
  • Blastocyst / physiology*
  • Cryopreservation*
  • Embryo Transfer* / adverse effects
  • Female
  • Fertility / drug effects
  • Fertility Agents, Female / administration & dosage*
  • Fertility Agents, Female / adverse effects
  • Fertilization in Vitro* / adverse effects
  • Humans
  • Infertility / blood
  • Infertility / diagnosis
  • Infertility / physiopathology
  • Infertility / therapy*
  • Live Birth
  • Ovulation Induction / adverse effects
  • Ovulation Induction / methods*
  • Pregnancy
  • Pregnancy Rate
  • Progesterone / blood*
  • Retrospective Studies
  • Risk Factors
  • Time Factors
  • Treatment Outcome
  • Up-Regulation

Substances

  • Biomarkers
  • Fertility Agents, Female
  • Progesterone